A study of method development and validation for estimation of Azelastine hydrochloride in nasal spray formulations by RP-HPLC method
A STUDY OF METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF AZELASTINE HYDROCHLORIDE
Abstract
A simple reverse-phase HPLC method for the estimation of Azelastine hydrochloride in nasal spray formulations has been developed. The method is simple, accurate, precise, specific and linear over the analysis range. This developed method has been validated according to International Conference on Harmonization (ICH) guideline with respect to system suitability, specificity, precision, linearity, accuracy, and robustness. An isocratic condition of mobile phase comprising Phosphate buffer (pH 3.1): Acetonitrile in a ratio of 60:40, v/v at a flow rate of 1.0 mL/minute over RP C18 (octadecylsilane (ODS), 250 × 4.6 mm, 5 µm, CHROMOSIL) column at ambient temperature was maintained. Besides, the chromatographic peak was observed sharp & symmetric. The proposed method was successfully applied for the estimation of the Azelastine hydrochloride in nasal spray formulation.
DOI
https://doi.org/10.22270/jddt.v8i6-s.2222References
Durham SR. The inflammatory nature of the allergic disease. Clin Exp Allergy 1998; 28(Suppl 6):20-4.
https://en.wikipedia.org/wiki/Inflammation
Lieberman P. Management of allergic rhinitis with a combination antihistamine/anti-inflammatory agent. J Allergy Clin Immunol 1999; 103:S400-4.
https://en.wikipedia.org/wiki/Azelastine.
https://pubchem.ncbi.nlm.nih.gov/compound/azelastine.
EUROPEAN PHARMACOPOEIA 5.0: 1038.
http://inventi.in/journal/article/impact/4/6033/pharm-analysis-quality-assurance/pi
ICH guideline, Q2(R1) step 4, Validation of Analytical Procedures: Text and Methodology (2005).
Published
Abstract Display: 1116 
PDF Downloads: 1066 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.